Numerous studies have shown that the immune system (particularly the cellular immune system in cancer patients) exhibits severe defects, including a reduction of CD3+CD4+ T cells, an increase in the number of CD3+CD8+ T cells, a decrease in the CD4+/CD8+ ratio and a depression of NK cell killing activity (8). This evidence concerns the gene CD8A and cancer.